Haemonetics
HAE
HAE
300 hedge funds and large institutions have $2.5B invested in Haemonetics in 2025 Q3 according to their latest regulatory filings, with 57 funds opening new positions, 95 increasing their positions, 118 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
19% less repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 118
38% less capital invested
Capital invested by funds: $4.05B → $2.5B (-$1.55B)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Holders
300
Holding in Top 10
1
Calls
$31.7M
Puts
$20.1M
Top Buyers
| 1 | +$104M | |
| 2 | +$45.5M | |
| 3 | +$36.1M | |
| 4 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$29.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$23.5M |
Top Sellers
| 1 | -$113M | |
| 2 | -$85M | |
| 3 | -$56.1M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$43.8M |
| 5 |
Neuberger Berman Group
New York
|
-$37.6M |
